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The potential mechanisms of action of polyphenols in nonalcoholic fatty liver disease (NAFLD) are overlooked. Here, we evaluate the beneficial therapeutic
effects of hydroxytyrosol (HT), the major metabolite of the oleuropein, in a nutritional model of insulin resistance (IR) and NAFLD by high-fat diet. Young male
rats were divided into three groups receiving (1) standard diet (STD; 10.5% fat), (2) high-fat diet (HFD; 58.0% fat) and (3) HFD+HT (10 mg/kg/day by gavage).
After 5 weeks, the oral glucose tolerance test was performed, and at 6th week, blood sample and tissues (liver and duodenum) were collected for following
determinations. The HT-treated rats showed a marked reduction in serum AST, ALT and cholesterol and improved glucose tolerance and insulin sensitivity,
reducing homeostasis model assessment index. HT significantly corrected the metabolic impairment induced by HFD, increasing hepatic peroxisome proliferator-
activated receptor PPAR-α and its downstream-regulated gene fibroblast growth factor 21, the phosphorylation of acetyl-CoA carboxylase and the mRNA
carnitine palmitoyltransferase 1a. HT also reduced liver inflammation and nitrosative/oxidative stress decreasing the nitrosylation of proteins, reactive oxygen
species production and lipid peroxidation. Moreover, HT restored intestinal barrier integrity and functions (fluorescein isothiocyanate-dextran permeability and
mRNA zona occludens ZO-1). Our data demonstrate the beneficial effect of HT in the prevention of early inflammatory events responsible for the onset of IR and
steatosis, reducing hepatic inflammation and nitrosative/oxidative stress and restoring glucose homeostasis and intestinal barrier integrity.
© 2016 Elsevier Inc. All rights reserved.Keywords: Nonalcoholic fatty liver disease; Olive oil polyphenols; Glucose tolerance; Liver inflammation; Insulin resistance; Duodenal permeability1. Introduction
The olive fruit and virgin olive oil are essential components of the
Mediterranean diet, a nutritional regimen gaining ever-increasing
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.content of phenolic compounds in virgin olive oil has demonstrated
antiinﬂammatory, antioxidant and antineoplastic activities [3–4].
Among these, hydroxytyrosol (HT), which is abundant in the aqueous
fraction of olive pulp, is a simple phenolic compound with marked
antioxidant activity [5–6]. A dose-dependent accumulation of HT and
its metabolites has been demonstrated in target metabolic and
vascular tissues [7], suggesting potential applications of HT to prevent
hepatic and cardiovascular diseases.
The antioxidant activity of oleuropein, the precursor of HT, is able
to reduce free-fatty acids (FFA)-induced hepatocellular steatosis in
HepG2 cells reducing the number and size of lipid droplets and
intracellular triglyceride accumulation [8]. Other in vitro studies have
conﬁrmed the hypolipidemic and antiinﬂammatory effect of HT [9,10],
modulating the activity of key enzymes involved in fatty acid
metabolism [i.e. acetyl-CoA carboxylase (ACC) and fatty acid syn-
thase], triglyceride synthesis and cholesterogenesis in hepatocytes.
This effect was higher than that of oleuropein or tyrosol [9]. HT
showed also antiinﬂammatory mechanism, inhibiting inducible nitric
oxide synthase (iNOS), cyclooxygenase (COX)-2 expression, tumor
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lipopolysaccharide-stimulated human monocytic THP-1 cell line [10].
Nonalcoholic fatty liver disease (NAFLD) is themost commoncause
of chronic liver disease. This condition is not only conﬁned to liver, but
there is now growing evidence that it is a multisystem disease [11].
The most important features of NAFLD are the aberrant lipid
accumulation in hepatocytes and the inﬂammatory progression to
steatohepatitis. Several mediators, as TNF-α, interleukin (IL)-6 and
COX-2, play a key role in the onset of insulin resistance (IR) and liver
inﬂammatory process, through inhibitory mechanisms on insulin
signaling, hepatocytes apoptosis and increased production of reactive
oxygen species (ROS) [12–13].
Some members of the nuclear receptor family are key regulators
not only of hepatic lipogenesis but also of hepatic and systemic
inﬂammation [14]. In particular, peroxisome proliferator-activated
receptor (PPAR)-α, mainly expressed in the liver, is involved in the
clearance of circulating and cellular lipids by controlling the
expression of lipogenic genes. In virtue of that, it is critically involved
in the onset and progression of steatosis and it currently represents a
therapeutic target in this disease [15].
To study the efﬁcacy and potential mechanisms of action of HT in
NAFLD, we used an experimental model of steatosis, feeding young
rats with a high-fat diet (HFD) [16]. Here, we demonstrate that HT is
able to prevent the early hepatic damage underlying steatosis and IR
onset, reducing inﬂammation and nitrosative/oxidative stress and
modulating lipid metabolism. Finally, we evaluated the beneﬁcial
effect of HT on duodenal permeability impaired by fat over nutrition,
limiting liver exposure to gut-derived detrimental factors.
2. Materials and methods
2.1. Ethics statement
All procedures involving animals and their care were conducted in conformity with
international and national law and policies (EU Directive 2010/63/EU for animal
experiments, ARRIVE guidelines and the Basel declaration including the 3R concept).
The procedures reported here were approved by the Institutional Committee on the
Ethics of Animal Experiments (CSV) of the University of Naples “Federico II” and by the
Ministero della Salute under protocol no. 20138-0040363. Before killing and prior to
serum and sample collection, animals, kept overnight fasted, were anesthetized by
enﬂurane and euthanized by an intraperitoneal injection of a cocktail of ketamine/
xylazine. As suggested by the animalwelfare protocol, all effortsweremade tominimize
animal suffering and to use only the number of animals necessary to produce reliable
scientiﬁc data.
2.2. Diets and animal model design
Standard (STD) and HFD were purchased from Laboratorio Dottori Piccioni
(Gessate, Milan, Italy). STD had 15% fat, 22% proteins and 63% carbohydrates, while
HFD had 58% of energy derived from fat, 18% from protein and 24% from carbohydrates.
STD and HFD contained 4.06 kcal/g and 5.56 kcal/g, respectively. In our experiment, we
administered HFD in young rats for 6 weeks to induce the early events of NAFLD due to
fat overnutrition, excluding age and gender inﬂuences [16]. The polyphenol derivative
HTwas synthesized in the laboratory of Pharmaceutical Chemistry of the Department of
Pharmacy of the University of Naples Federico II.
Male Sprague–Dawley rats (113.5±1.1 g; Harlan, Corazzano, Italy) were housed in
cages in a room kept at 22±1°C on a 12/12 h light/dark cycle. After weaning, rats were
divided into three groups (at least 6 rats for each group) as following: (1) STD, control
group receiving STD and water as drug vehicle by gavage; (2) HFD-fed animals receiving
vehicle; and (3) HFD-fed rats treated by gavagewith HT (HFD+HT, 10 mg/kg/day). After
5 weeks, all rats were subjected to the oral glucose tolerance test (OGTT). After 6 weeks,
blood sample was collected by cardiac puncture and serum was obtained. Liver and
duodenum tissues were excised and immediately frozen for following determinations.
2.3. Histological analysis of liver tissue
Liver sections were stained with hematoxylin and eosin or Oil Red O for the
morphological and intrahepatocyte lipid evaluations. Steatosis was graded on a scale of
0 (absence of steatosis), 1 (mild), 2 (moderate) and 3 (extensive). A double-blinded
examination of the sections was made independently by two veterinary pathologists
(OP and TBP) at a magniﬁcation ×20.2.4. OGTT and serum parameters
At the ﬁfth week of treatment, fasted rats received glucose (2 g/kg; per os) and
glycemia was measured at 0, 30, 60, 90 and 120 min after glucose administration.
Glucose levels were measured by the glucometer One Touch UltraSmart (Lifescan,
Milpitas, CA, USA).
All biochemical and hormonal parameters were measured in serum samples
prepared from blood collected at sixth week. Serum AST, ALT, cholesterol and glucose
were analyzed by standard automated procedures, according to manufacturer's
protocols (AST Flex reagent cartridge and ALT Flex reagent cartridge; Dade Behring
Inc., Newark, DE, USA). Insulin levels were also evaluated by ELISA assay (Millipore,
Billerica, MA, USA). As index of IR, homeostasis model assessment (HOMA) was
calculated, using the formula [HOMA=fasting glucose (mmol/L)×fasting insulin
(μU/ml)/22.5].
2.5. Real-time PCR
Total RNA, isolated from liver and small intestine, was extracted using TRIzol
Reagent (Bio-Rad Laboratories), according to the manufacturer's instructions. cDNA
was synthesized using a reverse transcription kit (NucleoSpin; MACHEREY-NAGEL
GmbH & Co., Düren, Germany) from 2 μg total RNA. PCRs were performed with a Bio-
Rad CFX96 Connect Real-Time PCR System instrument and software (Bio-Rad
Laboratories). The primer sequences are reported in Table 1. The PCR conditions were
10 min at 95°C followed by 40 cycles of two-step PCR denaturation at 95°C for 15 s and
annealing/extension at 60°C for 60 s. Each sample contained 1–100 ng cDNA in 2×
Power SYBRGreen PCR Master Mix (Bio-Rad Laboratories) and 200 nmol/L of each
primer (Euroﬁns MWG Operon, Huntsville, AL, USA) in a ﬁnal volume of 25 μl. The
relative amount of each studied mRNA was normalized to GAPDH as housekeeping
gene, and the data were analyzed according to the 2−ΔΔCT method. Before performing
any reaction, the efﬁciency of primers was set through a standard curve in the tissue
sample analyzed, and an ampliﬁcation efﬁciency of 100% was obtained.
2.6. Western blot analysis
Livers were homogenized and total protein lysates were subjected to SDS-PAGE.
Blots were probed with anti-nitrotyrosine (Nox-Tyr; Merck Millipore, Billerica, MA,
USA), anti-phospho-acetyl-CoA-carboxilase (pACC), anti-ACC type 2 or β (Cell
Signaling, Danvers, Massachusetts, USA) and anti-COX-2 (BD Transduction, Franklin
Lakes, NJ, USA). Western blot for anti-α-tubulin or glyceraldehyde 3-phosphate
dehydrogenase (GAPDH, Sigma-Aldrich; Milan Italy) was performed to ensure equal
sample loading.
2.7. ROS assay
The levels of ROS were determined as previously reported [17]. An appropriate
volume of freshly prepared tissue homogenate was diluted in 100 mM potassium
phosphate buffer (pH 7.4) and incubated with a ﬁnal concentration of 5 μM dichloro-
ﬂuorescein diacetate (Sigma-Aldrich) in dimethyl sulfoxide for 15 min at 37°C. The dye-
loaded samples were centrifuged at 12,500g per 10 min at 4°C. The pellet was mixed at
ice-cold temperatures in 5 ml of 100 mM potassium phosphate buffer (pH 7.4) and
again incubated for 60 min at 37°C. The ﬂuorescence measurements were performed
with a HTS-7000 Plus-plate-reader spectroﬂuorometer (Perkin Elmer, Wellesley,
Massachusetts, USA) at 488 nm for excitation and 525 nm for emission wavelengths.
ROSwere quantiﬁed from the dichloro-ﬂuorescein standard curve in dimethyl sulfoxide
(0–1 mM).
2.8. MDA measurement
Malondialdehyde (MDA) levels in the liver were determined as an indicator of lipid
peroxidation [18]. Tissues were homogenized in 1.15% KCl solution. An aliquot (200 μl)
of the homogenate was added to a reaction mixture containing 200 μl of 8.1% SDS,
1.5 ml of 20% acetic acid (pH 3.5), 1.5 ml of 0.8% thiobarbituric acid and 600 μl of
distilled water. Samples were then boiled for one hour at 95°C and centrifuged at 3000g
for 10 min. The supernatant absorbance was measured by spectrophotometry at
550 nm and the concentration of MDA was expressed as micromoles of MDA per
milligram of protein of cell homogenate. A standard curve was prepared using MDA
bisdimethylacetal as the source of MDA. All solutions were freshly prepared on the day
of the assay.
2.9. Measurement of gut permeability in vivo
In another set of experiments, after 6 weeks on HFD, rats were fasted for 6 h and
then gavaged with 4000-kDa ﬂuorescein isothiocyanate-labeled dextran (FITC-
dextran; TdB Consultancy AB, Uppsala, Sweden) diluted in water (500 mg/kg,
125 mg/ml). After 2 or 24 h, blood (500 μl) was collected from intracardiac puncture
and centrifuged (3000 rpm for 15 min at room temperature). FITC-dextran concentra-
tion in plasma was determined by spectroﬂuorimetry (excitation wavelength: 485 nm
and emission wavelength: 535 nm; HTS-7000 Plus-plate-reader, Perkin Elmer), as
previously described [19].
Table 1
Real-time PCR primer sequences
Target gene Forward primer (5′→3′) Reverse primer (3′→5′) Accession
number
TNF-α 5′-CATCTTCTCAAAACTCGAGTGACAA-3′ 3′-TGGGAGTAGATAAGGTACAGCCC-5′ NM_012675.3
IL-6 5′-ACAAGTGGGAGGCTTAATTACACAT-3′ 3′-TTGCCATTGCACAACTCTTTTC-5′ NM_012589.2
PPAR-α 5′-GTGCCTGTCCGTCGGGATGT-3′ 3′-GTGAGCTCGGTGACGGTCTC-5′ NM_013196.1
CPT1a 5′-CGCTCATGGTCAACAGCAACTACT-3′ 3′-CTCACGGTCTAATGTGCGACGA-5′ NM_031559.2
FGF21 5′-AGATCAGGGAGGATGGAACA-3′ 3′-ATCAAAGTGAGGCGATCCATA-5 NM_130752.1
ZO-1 5′-CCATCTTTGGACCGATTGCTG-3′ 3′-TAATGCCCGAGCTCCGATG-5′ NM_001106266.1
GAPDH 5′-GGCACAGTCAAGGCTGAGAATG-3′ 3′-ATGGTGGTGAAGACGCCAGTA-5′ NM_017008.4
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Data are presented asmean±SEM. Statistical analysis was performed by analysis of
variance test for multiple comparisons followed by Bonferroni's test, using GraphPad
Prism (GraphPad software, San Diego, CA, USA). Statistical signiﬁcancewas set at Pb .05.
3. Results
3.1. Effects of HT on histological studies and serum parameters
Hepatic tissue analysis from rats fed with HFD stained with
hematoxylin–eosin revealed a severe steatosis and inﬂammatory
damage. The histological pattern was characterized by microvesicular
steatosis and ballooning localized predominantly in zone 1, conﬁrmed
by Oil Red O staining (Fig. 1A and B).Fig. 1. HT effects on liver damage and lipid accumulation in HFD-fed rats. Parafﬁn-embedded se
Red O (B). Micrographs are representative pictures with original magniﬁcation ×20. Circulating
vs. STD; #Pb .05, and ##Pb .01 vs. HFD.Furthermore, the HFD-fed animals showed mild signs of liver
inﬂammation characterized by the presence of mixed inﬂammatory
cells, occasionally arranged in microgranulomas. No alterations were
observed in the liver of the rats fed with the standard diet. Liver
sections from animals fed with HFD and treated with HT showed
almost a complete resolution of the microvesicular steatosis and
ballooning and absence of liver inﬂammation.
Accordingly, the increase in serumAST, ALT and cholesterol in HFD
group was reduced by the polyphenol (Fig. 1C–E).
Weight gain of animals did not signiﬁcantly change among groups
after 6 weeks (STD: 228.50±18.70 g, HFD: 234.60±32.7 g and
HFD+HT: 207.30±16.15 g); accordingly, also fat mass did not vary
amonggroups (STD: 80.30±7.18 g, HFD: 83.12±4.84 g andHFD+HT:
74.28±5.96 g). Moreover, food intake, expressed as grams of foodctions of the liver (n=4 each group) were stained with hematoxylin–eosin (A) and Oil
AST (C), ALT (D) and CHOL (E) were measured (n=6, each group). *Pb .05 and **Pb .01
Fig. 2. Effect of HT on glucose homeostasis and IR. OGTT (A) in STD andHFD-fed rats (n=6, each group)was performed. Fasting glucose (B), insulin levels (C) andHOMA IR (D)were also
reported (n=6, each group). *Pb .05, **Pb .01 and ***Pb .001 vs. STD; #Pb .05, and ##Pb .01 vs. HFD.
Fig. 3. Effect of HT treatment onmetabolic impairment in liver fromHFD-fed rats. PPAR-α (A) and FGF21 (B)mRNA abundance in the liver extractswere quantiﬁedby real-time PCR (n=
6each group). A representative blot of pACC and ACC and the ratio from densitometric analysis of bands from all samples are also shown (C). Liver CPT1a (D)mRNA (relative expression
to STD) is also reported. Data are mean±SEM of 6 rats per group. *Pb .05 and ***Pb .001 vs. STD; #Pb .05 and ##Pb .01 vs. HFD.
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Fig. 4. HT treatment reduces TNF-α and IL-6 gene expression and COX-2 in liver. TNF-α
(A) and IL-6 (B) mRNA expression (relative expression to STD) are reported (n=6 each
group). Panel C shows representative western blot analysis of COX-2 protein expression
and densitometric analysis of bands from all samples. Data aremean±SEM of 6 rats per
group. *Pb .05 vs. STD; #Pb .05 and ##Pb .01 vs. HFD.
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0.58 g/day/rat) or treated rats with HT (14.23±0.84 g/day/rat).3.2. Effect of HT on glucose homeostasis and IR
After the 5-week treatment, HT reduced basal glucose level
measured before glucose load. In OGTT, HT treatment caused a
signiﬁcant decrease of glycemia at 120 min (Fig. 2A). At 6 weeks,
fasting serum glucose (Fig. 2B) and insulin levels (Fig. 2C) were
signiﬁcantly higher in HFD rats than STD and HT normalized both
parameters. Accordingly, IR assessed byHOMA indexwas signiﬁcantly
reduced by HT (Fig. 2D).3.3. Modulation of hepatic lipid metabolism by HT
PPAR-α mRNA expression was deeply reduced by HFD and
restored by HT (Fig. 3A). The evaluation of ﬁbroblast growth factor
FGF21 and liver carnitine palmitoyltransferase CPT1a, as a down-
stream target genes of PPAR-α, showed a similar proﬁle of expression
of their transcription factor (Fig. 3B and D). Accordingly, HT also
increased the phosphorylation of ACC (Fig. 3C), indicating an increase
in hepatic metabolism and oxidation of fatty acids in HT-treated rats.
3.4. HT treatment counteracts hepatic inflammation and oxidative stress
TNF-α, IL-6 and COX-2 are important proinﬂammatory mediators
involved in the liver damage and the pathogenesis of hepatic IR. As
shown in Fig. 4A and B, HFD induced an increase in TNF-α and IL-6
mRNA levels compared to STD group, and this effect was prevented by
HT treatment. Similarly, the antiinﬂammatory effect of the polyphenol
was conﬁrmed by the reduction of COX-2 expression (Fig. 4C).
HFD caused a signiﬁcant increase of oxidative damage from ROS
and reactive nitrogen species (RNS), which mainly contribute to the
hepatic damage. HT reduced nitrosylation of proteins and decreased
ROS production (Fig. 5A and B, respectively). Moreover, we evaluated
the levels ofMDA, as amarker of lipid peroxidation,whichwere higher
in HFD than in STD group. HT treatment signiﬁcantly decreased MDA
levels (Fig. 5C).
3.5. Effect of HT on gut permeability and intestinal barrier functions
As a consequence of HFD feeding, epithelial barrier integrity was
compromised. Indeed, HFD group showed a signiﬁcant increase in gut
permeability measured in vivo and determined by plasmatic levels of
FITC-labeled dextran at 2 and 24 h (Fig. 6A). This increased
permeability was counteracted by HT and the effect was related
with the restoration of zona occludens (ZO)-1 mRNA transcript in
duodenum (Fig. 6B).
4. Discussion
The beneﬁcial effects of the olive oil have been attributed to its
several phenolic constituents (i.e. oleocanthal and oleuropein)
[20–23]. Here, we focused on HT, the major metabolite of oleuropein
[8,24], and showed its protective effect in limiting the metabolic
impairment and early inﬂammatory events underpinning the onset of
IR and hepatic steatosis in a rat model of NAFLD induced by HFD. To
study the capability of HT in preventing liver steatosis progression on
the onset of the disease, we chose 6-week feeding, as experimental
time, that mimics the early phase of liver steatosis without a
signiﬁcant increase of body fat accumulation.
In our experiments, HT restores glucose homeostasis and insulin
sensitivity, reducing fasting glycemia, insulinemia and HOMA index.
Furthermore, this oleuropein derivative prevents the increase in
hepatic damage markers, such as AST and ALT, and limits histological
modiﬁcations, induced by fat overnutrition and early features of
steatosis.
We have previously described this model characterized by an
increase in serum lipid proﬁle (nonesteriﬁed fatty acids, LDL and
cholesterol) and lipid accumulation in the hepatocytes [16,25].
In NAFLD and relatedmetabolic diseases, it has been demonstrated
an alteration of sterol regulatory element-binding protein (SREBP)-1
and PPAR-α pathways, which regulate lipogenesis and lipid β-oxidation
and catabolism, respectively [26–27]. In particular, data on PPAR-α−/−
mice fed with high-fat diet have shown abnormal lipid accumulation in
hepatocytes,which is consistentwith a crucial role for PPAR-α in hepatic
lipid metabolism and fatty acid oxidation [28].
Fig. 5. Effect of HT on nitrosative and oxidative stress. Protein nitrosylation in liver from STD and HFD rats treated or not with HT is shown (A). ROS production (B) andMDA content (C)
are also reported. Values are reported as mean±SEM of at least 6 animals. *Pb .05 and **Pb .01 vs. STD; #Pb .05 vs. HFD.
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reduction of PPAR-α expression in liver [16] and, according to our
ﬁndings, the administration of a PPAR agonist or probiotics restores
PPAR-α and improves hepatic steatosis [29–30]. Accordingly, here, we
found that HFD feeding reduces PPAR-α mRNA liver expression and
the phosphorylation of ACC, an enzyme involved in initial phase of
fatty acid metabolism. This enzyme, indeed, belonging to the AMP-
activated protein kinase (AMPK) pathway, is involved in the
regulation of CPT1 activity [31].
Previously, a mechanistic study of the PGC1α activation signaling
pathway demonstrated that HT is an activator of AMPK and also
up-regulates gene expression of PPAR-α, CPT1 and PPAR-γ in
adipocytes [32].Fig. 6. HT treatment improves intestinal permeability and restores duodenal ZO-1 gene express
dextran in plasma of STD, HFD and HFD+HT rats (n=6 each group) 2 and 24 h postadminist
group). Values are reported as mean±SEM of at least 6 animals. *Pb .05 vs. STD; #Pb .05 and #In particular, AMPK induces the phosphorylation of ACC, a
modiﬁcation that inactivates the enzyme, reducing the formation of
malonyl-CoA. The decrease in malonyl-CoA synthesis, in turn, reduces
liver CPT1 inhibition, thus prompting adequate shutting of fatty acids
into the mitochondria and hence their oxidation [26]. Here, we show
that HT increases the phosphorylation of ACC and the transcription of
liver CPT1a, both remarkably reduced by HFD. The restoration of CPT1
was consistent with the normalization of its transcriptional regulatory
factor PPAR-α. Our results are in agreementwith a previous study [33],
in which resveratrol, another phenolic compound, triggering the
phosphorylation of ACC and activating CPT1a, was able to increase
liver fatty acid oxidation and to improve liver steatosis, induced by an
obesogenic diet.ion. Panel A shows the measurement of gut permeability by appearance of FITC-labeled
ration. mRNA expression for ZO-1 (B) in the duodenal tissue is also shown (n=6 each
#Pb .01 vs. HFD.
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levels but also restores the expression of its downstream-regulated
gene FGF21 in the liver. As known, liver production of FGF21, a
cytokine/hormonewhose transcription is regulated by PPAR-α [34], is
required for the physiological activation of hepatic lipid oxidation and
triglyceride clearance [35].
Our results conﬁrm data previously reported by other authors in
adipocytes [32], demonstrating that the strong effect of HT on
phosphorylation of AMPK and ACC was consistent with the decrease
in FFA and the increase in CTP1 and PPAR-α as indexes of increased
fatty acid oxidation. Our data are consistent with these ﬁndings and
indicate that HT might be potentially effective in increasing fatty acid
oxidation and insulin sensitivity.
Liver and other tissues, such as skeletalmuscle and adipose tissues,
play a central role inmetabolic homeostasis, predisposing whole body
to inﬂammation when metabolism is compromised. In fact, inﬂam-
mation is largely considered the driving force for progression or
exacerbation of metabolic diseases, such as dyslipidemia and NAFLD.
We and others have demonstrated that PPAR-α is an important
regulator of inﬂammatory process [14,36–37]. The antiinﬂammatory
effects of all classes of PPARs rely primarily on genomicmechanisms of
transrepression of transcriptional factors (i.e. NF-κB), which induce
the reduction of proinﬂammatory cytokines and enzymes [38].
Therefore, similarly to PPAR-γ, it is conceivable that PPAR-α activity
could modulate metabolic disorders associated with inﬂammation
either through its metabolic activity or its antiinﬂammatory effects.
Recently, the current knowledge concerning the main biological
properties of HT was summarized, including its antiinﬂammatory and
cardioprotective effects [24]. Here, we demonstrated that HT
signiﬁcantly reduces the expression of inﬂammatory cytokines
(TNF-α and IL-6) and COX-2 in the liver, conﬁrming its antiinﬂamma-
tory activity, likely associated to its ability in controlling metabolic
alterations through PPAR-α recover. Previous data examined the role
of cytokine- and enzyme-induced inﬂammation and their link with IR
and fatty liver [39–40]. Metabolic dysregulation, mitochondrial
impairment and oxidative stress have a crucial role in determining
hepatocyte damage, contributing to inﬂammatory process and NAFLD
progression [41]. In particular, mitochondrial dysfunction is mainly
related to the IR and lipotoxicity due to FFA excess [42]. Mitochondrial
impairment causes enhanced ROS production, which in turn self-
sustains organelle damage. In particular, products of cellular lipid
peroxidation (i.e. MDA and 4-hydroxynonenal) associated to inﬂam-
matory cytokines (i.e. TNF-α) contribute tomitochondrial dysfunction
by interfering with mitochondrial respiratory chain and by forming
superoxide anion [43]. Indirectly, TNF-α promotes mitochondrial
dysfunction, increasing RNS as consequence of iNOS induction [44],
and the administration of uric acid or anti-TNF antibodies was able to
improve this dysfunction [45].
The antioxidant activity of HT has been well examined in
physiological and pathological conditions [5–6,20,46–48], but its
role in the oxidative damage in NAFLD is still largely unexplored. For
this reason,we evaluatedROS- andRNS-induced stress inHFD-fed rats
receiving HT. Here, HT signiﬁcantly reduces ROS production, MDA
levels and protein nitrosylation.
Ourdata are inagreementwith recentdata reportingneuroprotective
effects of HT in type 2 diabetes animal model [49], where HT improves
mitochondrial function and reduces oxidative stress potentially through
activation of the AMPK pathway in the brain of db/db mice.
Another key role in the pathogenesis and ongoing of NAFLD is
playedby gut-derived endotoxin that reaches the liverwhen intestinal
integrity and function are compromised, impairing liver homeostasis
and sustaining tissue inﬂammation [50]. The polyphenol HT recovers
the impairment of gut integrity, as evidenced by the reduction of
plasmatic FITC-dextran levels and the increase in duodenal mRNA ZO-
1, an important TJ protein that was signiﬁcantly altered by HFD.In summary, our data clearly demonstrate thatHTprotects the liver
from damage caused by HFD. This effect was mediated by a reduction
in hepatic fat accumulation (through increased fatty acid β-oxidation)
and in liver oxidative stress (through the reduction of protein
nitrosylation, ROS and MDA) and by inﬂammation (through modu-
lation of enzyme and cytokines related to hepatic inﬂammation).
Moreover, HT recovers the HFD-induced alteration of gut integrity,
underpinned to the major exposure of the liver to gut-derived toxins
and metabolites, which in turn contributes and increases the liver
inﬂammation favoring the progression of steatosis in steatohepatitis.
In conclusion, our data show antioxidant, antiinﬂammatory and
protective effect of the polyphenol HT in NAFLD, indicating the
beneﬁcial effects of virgin olive oil inMediterranean diet likely related
to this compound, among all its phenolic components. Indeed,
consumption of virgin olive oil enriched in HT, combined with
appropriate and balanced diet, could be considered an available
strategy to prevent early events of liver steatosis and its related
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